JOHNSON & JOHNSON
JNJ
56 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Sale | 89,654 | $242.80 | $21.8M | 14,000(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 53,931 | $243.00 | $13.1M | 10,658(D) | View → |
| Feb 18, 2026 | Feb 19 2:11 AM | Timothy SchmidEVP, WW Chair, MedTech | Sale | 22,623 | $244.33 | $5.5M | 26,769(D) | View → |
| Feb 17, 2026 | Feb 19 2:11 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Sale | 6,197 | $243.39 | $1.5M | 23,003(D) | View → |
| Feb 18, 2026 | Feb 18 4:14 PM | Schmid Timothy | Proposed Sale | 22,623 | $244.33 | $5.5M | — | View → |
| Feb 17, 2026 | Feb 17 9:10 PM | Broadhurst Vanessa | Proposed Sale | 6,197 | $243.39 | $1.5M | — | View → |
| Feb 17, 2026 | Feb 17 7:52 PM | Swanson James D. | Proposed Sale | 20,521 | $242.70 | $5.0M | — | View → |
| Feb 17, 2026 | Feb 17 7:43 PM | Wolk Joseph J | Proposed Sale | 89,654 | $242.80 | $21.8M | — | View → |
| Feb 17, 2026 | Feb 17 5:44 PM | REED JOHN C | Proposed Sale | 53,931 | $243.00 | $13.1M | — | View → |
| Feb 13, 2026 | Feb 13 7:33 PM | Swanson James D. | Proposed Sale | 41,559 | $243.73 | $10.1M | — | View → |
| Feb 5, 2026 | Feb 5 9:31 PM | Forminard Elizabeth | Proposed Sale | 6,226 | $237.90 | $1.5M | — | View → |
| Jan 26, 2026 | Jan 28 11:07 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 100,000 | $221.23 | $22.1M | 30,852(I) | View → |
| Jan 26, 2026 | Jan 26 9:57 PM | Joaquin Duato | Proposed Sale | 100,000 | $220.14 | $22.0M | — | View → |
| Oct 17, 2025 | Oct 17 2:23 PM | REED JOHN C | Proposed Sale | 21,721 | $192.71 | $4.2M | — | View → |
| Sep 4, 2025 | Sep 4 6:37 PM | Taubert Jennifer L | Proposed Sale | 56,471 | $177.81 | $10.0M | — | View → |
| Aug 29, 2025 | Aug 29 7:36 PM | Forminard Elizabeth | Proposed Sale | 9,570 | $177.20 | $1.7M | — | View → |
| Aug 22, 2025 | Aug 22 5:58 PM | Duato Joaquin | Proposed Sale | 125,824 | $180.04 | $22.7M | — | View → |
| Aug 15, 2025 | Aug 15 7:57 PM | Wolk Joseph J | Proposed Sale | 16,820 | $176.91 | $3.0M | — | View → |
| Jul 17, 2025 | Jul 17 8:05 PM | REED JOHN C | Proposed Sale | 19,137 | $163.55 | $3.1M | — | View → |
| Feb 25, 2025 | Feb 25 8:05 PM | Decker Robert J | Proposed Sale | 6,999 | $165.88 | $1.2M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 27 10:01 PM | Paula A JohnsonDirector | Grant/Award | 975 | — | 5,359.397(D) | View → |
| Apr 23, 2026 | Apr 27 9:48 PM | Marillyn A HewsonDirector | Grant/Award | 975 | — | 15,487.939(D) | View → |
| Apr 23, 2026 | Apr 27 9:43 PM | Jennifer A DoudnaDirector | Grant/Award | 975 | — | 10,899.171(D) | View → |
| Apr 23, 2026 | Apr 27 9:38 PM | Mary C BeckerleDirector | Grant/Award | 975 | — | 16,797.739(D) | View → |
| Mar 10, 2026 | Mar 13 1:31 AM | Marillyn A HewsonDirector | Grant/Award | 206.492 | — | 14,512.94(D) | View → |
| Mar 4, 2025 | Mar 13 1:31 AM | Marillyn A HewsonDirector | Grant/Award | 75.256 | — | 14,306.449(D) | View → |
| Mar 10, 2026 | Mar 13 12:39 AM | Daniel E PintoDirector | Grant/Award | 129.058 | — | 462.069(D) | View → |
| Mar 10, 2026 | Mar 13 12:37 AM | Eugene A. WoodsDirector | Grant/Award | 154.869 | — | 5,240.094(D) | View → |
| Feb 27, 2026 | Mar 3 9:21 PM | Robert J DeckerVP Corporate Controller | Option Exercise | 4,075 | $115.67 | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 20,521 | $164.62 | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Grant/Award | 20,846 | $243.45 | 1,397(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 1,201 | — | 1,418(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | James D. SwansonEVP, CIO | Option Exercise | 51,418 | $165.89 | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Grant/Award | 18,162 | $243.45 | 1,217(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 1,241 | — | 1,268(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 14,357 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 994 | — | 1,150(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Grant/Award | 21,781 | $243.45 | 1,459(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Kristen MulhollandEVP, Chief HR Officer | Option Exercise | 4,012 | — | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 64,693 | $131.94 | 33,000(D) | View → |